Switch Edition
Home

>>

Industry

>>

Compliance and governance

>>

Free Meningococcal B Vaccine f...

COMPLIANCE AND GOVERNANCE

Free Meningococcal B Vaccine for Tasmanian Infants under $4 Million Program 'A Game-Changer for Families'

Free Meningococcal B Vaccine for Tasmanian Infants under $4 Million Program 'A Game-Changer for Families'
The Silicon Review
01 July, 2026
Author: Vinay Kumar

Tasmania has launched a $4 million program offering free meningococcal B vaccines to all infants under one year old, making it the first state to provide universal access to the potentially life-saving jab. The Silicon Review examines how the initiative aims to protect the state's youngest residents from a disease that can kill within hours.

Tasmania is leading the nation in infant health protection. The state government has announced a $4 million program offering free meningococcal B vaccines to all infants aged less than 12 months, the first universal program of its kind in Australia.

The meningococcal B vaccine, which is typically only available privately at a cost of approximately $130 per dose, is being made freely available to all Tasmanian infants regardless of their family's financial situation.

Premier Jeremy Rockliff said the move would protect the state's most vulnerable residents from a devastating disease that can progress from mild symptoms to death within hours.

The program, expected to reach approximately 6,000 infants annually, aligns with national immunisation recommendations and follows similar initiatives in the United Kingdom, where routine infant meningococcal B vaccination has been in place since 2015.

"It doesn't matter what postcode you live in or what your bank balance is every Tasmanian family deserves access to the best protection against this devastating disease," said Health Minister Jacquie Petrusma in announcing the program.

Meningococcal B is the most common cause of meningococcal disease in Australia, with infants under one year old at the highest risk. The disease can cause meningitis (inflammation of the brain and spinal cord) and septicaemia (blood poisoning), leading to permanent disability or death.

The program has been welcomed by health professionals, with the Australian Medical Association Tasmanian branch president Dr John Saul describing it as "a game-changer for Tasmanian families" that would "give parents peace of mind they have done everything they can to protect their baby."

Here is the question this program raises. Tasmania has chosen to spend $4 million protecting infants from a disease that is rare but devastating a disease that can kill a child within hours of the first symptoms appearing. When other states have weighed the cost and decided against universal free access, is Tasmania's decision a model for the nation or a luxury only a smaller population can afford?

The vaccine will be available through GPs and community immunisation clinics from July 1. Parents of infants born on or after that date will be eligible for the free program.

As Tasmania rolls out its free meningococcal B vaccine program for infants, The Silicon Review asks a final question. When the cost of a vaccine can be the difference between life and death, should any Australian child be denied access or should Tasmania's bold move finally force the nation to follow suit?

FAQ:

Q: What is the free meningococcal B vaccine program in Tasmania?
A: Tasmania has launched a $4 million program offering free meningococcal B vaccines to all infants less than 12 months of age, making it the first universal program of its kind in Australia.

Q: Who is eligible for the free meningococcal B vaccine in Tasmania?
A: All infants under 12 months of age in Tasmania are eligible for the free vaccine, regardless of their family's financial situation.

Q: How much does the meningococcal B vaccine usually cost?
A: The meningococcal B vaccine typically costs approximately $130 per dose when purchased privately.

Q: When does the Tasmanian meningococcal B vaccine program start?
A: The program starts from July 1, with parents of infants born on or after that date eligible for the free vaccine.

Q: Why is the meningococcal B vaccine important for infants?
A: Meningococcal B is the most common cause of meningococcal disease in Australia, and infants under one year old are at the highest risk of infection, which can lead to death within hours.

Comments

Loading comments…
Loading comments…

MOST VIEWED ARTICLES

RECOMMENDED NEWS

Client-Speak Magazine Subscribe Newsletter Video
Magazine Store
May Edition Cover
πŸš€ NOMINATE YOUR COMPANY NOW πŸŽ‰ GET 10% OFF πŸ† LIMITED TIME OFFER Nominate Now β†’